XML 69 R58.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Discontinued Operations - Summary of Financial Results (Details) - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment loss $ 120,489 $ 60,504 $ 16,773
Loss from discontinued operations (116,159) (100,389) (46,381)
Discontinued Operations, Held-for-sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Deferred revenue, current 8,723 4,466  
Deferred revenue, net of current portion 19,410 7,482  
Revenue 12,307 9,396 11,518
Impairment loss 89,679 60,504 2,950
Loss on disposal   5,057  
Operating expenses 126,885 111,509 53,498
Operating loss (114,578) (102,113) (41,980)
Other expense, net (272) (1,757) (7,506)
Equity in net loss of affiliates (4,314) (2,622) (1,847)
Income tax benefit (119,164) (106,492) (51,333)
Income tax benefit 3,005 6,103 4,952
Loss from discontinued operations (116,159) (100,389) (46,381)
TS Biotechnology Sale | Discontinued Operations, Held-for-sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Deferred revenue, current 8,723 4,466  
Deferred revenue, net of current portion 19,410 7,482  
Revenue 12,307 9,396 11,518
Operating expenses 116,091 111,039 53,028
Operating loss (103,784) (101,643) (41,510)
Other expense, net (272) (1,757) (7,506)
Equity in net loss of affiliates     0
Income tax benefit (104,056) (103,400) (49,016)
Income tax benefit 3,005 6,103 4,952
Loss from discontinued operations (101,051) (97,297) (44,064)
EnviroFlight Sale | Discontinued Operations, Held-for-sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Deferred revenue, current 0 0  
Deferred revenue, net of current portion 0 0  
Revenue 0 0 0
Operating expenses 10,794 470 470
Operating loss (10,794) (470) (470)
Other expense, net 0 0 0
Equity in net loss of affiliates (4,314) (2,622) (1,847)
Income tax benefit (15,108) (3,092) (2,317)
Income tax benefit 0 0 0
Loss from discontinued operations (15,108) (3,092) (2,317)
TS Biotechnology Holdings LLC and Enviro Flight LLC | Discontinued Operations, Held-for-sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Impairment loss 89,679 60,504 2,950
Related Parties, Aggregated | TS Biotechnology Sale | Discontinued Operations, Held-for-sale      
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Deferred revenue, current 1,243 443  
Deferred revenue, net of current portion 6,836 7,455  
Revenue $ 3,042 $ 4,665 $ 8,185